9 Menopause Myths Still Repeated by Gynecologists in Clinic That Harm Women
There is something particularly disorienting about leaving a doctor's appointment with advice that turns out to be wrong. So many women have been told their symptoms are 'just stress,' or that they're too young for perimenopause, or that HRT is too risky to even discuss — and they walked away believing it. The gap between what the evidence says and what gets said in clinic is one of the things that made building this site feel genuinely urgent.
Learn more about Rose →"You're Too Young to Be in Perimenopause"
Perimenopause can begin in the late 30s, and the average onset is around age 47 — meaning a significant proportion of women are symptomatic well before their mid-40s. Irregular cycles, sleep disruption, anxiety, and vasomotor symptoms in a woman in her late 30s or early 40s deserve hormonal investigation, not dismissal. Delaying that recognition delays treatment and leaves women without an explanation for symptoms that are actively affecting their quality of life.
"HRT Is Too Risky for Most Women"
The 2002 Women's Health Initiative study created a generation of HRT-averse clinicians, but the data has since been substantially reanalysed and recontextualised. For healthy women under 60 who are within 10 years of their final menstrual period, the benefits of hormone therapy — including cardiovascular protection, bone density maintenance, and symptom relief — generally outweigh the risks. Major bodies including the British Menopause Society, the Menopause Society (formerly NAMS), and the International Menopause Society have updated their guidance accordingly, yet the 2002 headlines still drive clinical decision-making in many practices.
"Weight Gain in Menopause Is Inevitable and Irreversible"
Hormonal changes during menopause do shift fat distribution — particularly toward the abdomen — and can reduce resting metabolic rate, but substantial weight gain is not an unavoidable biological destiny. Resistance training, adequate protein intake, sleep quality, and in some cases hormonal support can meaningfully influence body composition during this transition. Framing weight gain as simply inevitable discourages women from interventions that have real evidence behind them and can make them feel powerless over their own bodies.
"Hot Flushes Are the Main Symptom to Watch For"
Vasomotor symptoms like hot flushes and night sweats are the most recognised features of menopause, but the symptom list is far broader and frequently underdiagnosed. Joint pain, brain fog, anxiety, low mood, itchy skin, heart palpitations, urinary urgency, and changes in body odour are all documented hormonal symptoms that women commonly report — and commonly have dismissed. When clinicians anchor their diagnostic thinking to hot flushes alone, women with atypical presentations go unrecognised for years.
"You Should Wait Until Periods Have Stopped to Start HRT"
The perimenopause — the years of hormonal fluctuation before the final period — is often when symptoms are at their most severe, and it is also the window when starting hormone therapy may confer the greatest long-term cardiovascular benefit. Waiting for 12 consecutive period-free months (the clinical definition of menopause) before initiating HRT has no strong evidence basis and simply prolongs unnecessary suffering. Current evidence supports discussing and offering HRT to symptomatic perimenopausal women, not just post-menopausal ones.
"Antidepressants Are a Good First-Line Option for Menopause Mood Symptoms"
When women present with low mood, tearfulness, or anxiety in their mid-to-late 40s, antidepressants are frequently prescribed without any assessment of hormonal status — even when the symptom onset clearly tracks with menstrual changes. Perimenopausal mood symptoms driven by oestrogen fluctuation do not respond to SSRIs the way clinical depression does, and prescribing antidepressants in this context often produces little benefit while delaying appropriate hormonal treatment. This is not to say antidepressants have no role in menopause care, but defaulting to them before considering hormones represents a significant clinical gap.
"Vaginal Dryness Is Just a Cosmetic Discomfort"
Genitourinary syndrome of menopause (GSM) — which includes vaginal dryness, thinning, reduced lubrication, and urinary symptoms — is a chronic, progressive condition that worsens over time without treatment, unlike hot flushes which often diminish. It can cause pain with intercourse, recurrent urinary tract infections, urinary urgency, and a significant decline in quality of life and intimate relationships. Calling it a minor discomfort trivialises a condition that has effective, low-risk treatments — including topical oestrogen — and causes real, lasting harm when left unaddressed.
"A Normal FSH Test Means You're Not in Perimenopause"
Follicle-stimulating hormone (FSH) levels fluctuate dramatically during perimenopause and a single normal reading does not rule out the transition — yet women are regularly told this by clinicians who are over-relying on a single blood test. The diagnosis of perimenopause is primarily clinical, based on age, symptom pattern, and menstrual history, with blood tests playing only a supporting role. Using a single FSH result to dismiss perimenopause as a diagnosis is one of the most common — and most consequential — clinical errors in this space.
"You Only Need HRT for a Few Years — Then You Must Stop"
The idea that HRT should be automatically stopped after two or five years has no firm evidence base and originates from a misreading of WHI study timelines applied to a different population. For many women, the protective effects of HRT on bone density, cardiovascular health, and cognitive function are ongoing — and stopping abruptly can trigger the return of severe symptoms as well as accelerating bone loss. The decision about duration should be made individually, with regular benefit-risk reviews, rather than applying an arbitrary cut-off that the evidence does not support.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.